rilematovir [extracellular region]

Stable Identifier
R-ALL-9845118
Type
ChemicalDrug
Compartment
extracellular region
Locations in the PathwayBrowser
Expand all
Literature References
PubMed ID Title Journal Year
37422079 A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection

Nilsson, AC, Pullman, J, Napora, P, Luz, K, Gupta, A, Draghi, J, Guzman Romero, AK, Aggarwal, N, Petrova, G, Ianus, J, Vijgen, L, Scott, J, Sinha, R, Rusch, S, Huntjens, D, Bertzos, K, Stevens, M

Clin Microbiol Infect 2023
External Reference Information
External Reference
Rilematovir [PubChem Compound:118892432]
Participates
as a member of
Disease
Cross References
Mondo
Cite Us!